Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-03-08 @ 1:51 AM
Study NCT ID:
NCT05337735
Status:
SUSPENDED
Last Update Posted:
2025-10-09
First Post:
2022-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Microsatellite High Cancers | View |
| None | Peritoneal Mesothelioma | View |
| None | Extrapulmonary High Grade | View |
| None | Neuroendocrine Carcinomas | View |
| None | Cervical Carcinoma | View |
| None | Hodgkin's Lymphoma | View |
| None | Pleural Mesothelioma | View |
| None | Small Cell Lung Cancer | View |
Keywords: